Antimicrobial and enhancement of the antibiotic activity by phenolic compounds: Gallic acid, caffeic acid and pyrogallol

Microbial Pathogenesis

Volumn 99, Issue , 2016, Pages 56-61

  Lima, Valéria N ^a   Oliveira Tintino, Cícera D M ^a   Santos, Enaide S ^a   Morais, Luís P ^a   Tintino, Saulo R ^a   Freitas, Thiago S ^a   Geraldo, Yuri S ^b   Pereira, Raimundo L S ^a   Cruz, Rafael P ^a   Menezes, Irwin R A ^a   Coutinho, Henrique D M ^a  

^a REGIONAL UNIVERSITY OF CARIRI   (Brazil)

^b Faculdade Leao Sampaio   (Brazil)

Author keywords

Caffeic acid; Gallic acid; Pyrogallol; Synergistic effect

Indexed keywords

CAFFEIC ACID; FLUCONAZOLE; GALLIC ACID; GENTAMICIN; IMIPENEM; NORFLOXACIN; PHENOL DERIVATIVE; PYROGALLOL; ANTIINFECTIVE AGENT; CAFFEIC ACID DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BROTH DILUTION; CANDIDA TROPICALIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ESCHERICHIA COLI; GROWTH INHIBITION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; BACTERIUM; CANDIDA; DRUG EFFECTS; DRUG POTENTIATION; MICROBIAL SENSITIVITY TEST;

ANTI-INFECTIVE AGENTS; BACTERIA; CAFFEIC ACIDS; CANDIDA; DRUG SYNERGISM; GALLIC ACID; MICROBIAL SENSITIVITY TESTS; PYROGALLOL;

EID: 84981188222     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2016.08.004     Document Type: Article

References (38)

1. [1] Santos, N.Q., A Resistência Bacteriana no contexto da infecção Hospitalar. Texto Contexto Enferm. 1 (2004), p.64–70.
2. [2] Santos, N.Q., Infecção Hospitalar: uma Reflexão Histórico-crítica. 1997, UFSC, Florianópolis-SC, Brazil.
3. [3] Casadevall, A., Antibody-based therapies for emerging infectious diseases. Emerg. Infect. Dis. 2 (1996), 200–208.
4. [4] Verhoeff, J., Beaujean, D., Vlok, H., Baars, A., Meyler, A., Werkwn, V.D.C., A dutch approach to methicillin-resistance Staphylococcus aureus. Eur. J. Clin. Microbiol. 18 (1999), 461–466.
5. [5] Murray, P.K.S., Rosenthal, G.S., Kobayashi, M.A., Pfaller, Microbiologia Médica. fourth ed., 2004, Elsevier, Rio de Janeiro-RJ, Brazil.
6. [6] Scotland, S.M., Day, N.P., Willshaw, G.A., Rowe, B., Cytotoxic entero pathogenic Escherichia coli. Lancet 1 (1980), 86–90.
7. [7] Konowalchuk, J., Speirs, J.I., Stavric, S., Vero response to a cytotoxin of Escherichia coli. Infect. Immun. 18 (1977), 775–779.
8. [8] Hughes, C., Muller, D., Hacher, J., Goebel, W., Genetics and pathogenic role of Escherichia coli haemolysin. Toxicon 20 (1982), 247–252.
9. [9] Kantarcioglu, A.S., Yucel, A., Phospholipase and protease activities in clinical Candida isolates with references to the source of strins. Mycoses 45 (2002), 160–165.
10. [10] Morais-Braga, M.F.B., Sales, D.L., Carneiro, J.N.P., Machado, A.J.T., Santos, A.T.L., Freitas, M.A., Bezerra-Martins, G.M.A., Leite, N.F., Matos, Y.M.L.S., Tintino, S.R., Souza, D.S.L., Menezes, I.R.A., Ribeiro-Filho, J., Costa, J.G.M., Coutinho, H.D.M., Psidium guajava L. and Psidium brownianum Mart ex DC.: chemical composition and anti and Candida effect in association with fluconazole. Microb. Pathog. 95 (2016), 200–207.
11. [11] Coutinho, H.D.M., Factors influencing the virulence of Candida spp. West Indian Med. J. 58 (2009), 160–163.
12. [12] Dignani, M.C., Solomkin, J.S., Anaissie, E., Candida. Anaissie, E., McGinnis, M.R., Pfaller, M.A., (eds.) Medical Mycology, 2003, Churchill Livingstone, Philadelphia, USA.
13. [13] Lopes, A.C., Tratado de clínica médica, vol. 3, 2006, ROCA, São Paulo-SP, Brazil.
14. [14] Bravo, L., Polyphenols: chemistry, dietarysources, metabolism, and nutritional significance. Nutr. Ver. 56 (1998), 317–333.
15. [15] Grundhöfer, P., Niemetz, R., Schilling, G., Gross, G.G., Biosynthesis and subcellular distribution of hydrolyzable tannins. Phytoch 57 (2001), 915–927.
16. [16] Mason, T.L., Wasserman, B.P., Inactivation of red beet beta-glucan synthase by native andoxidized phenolic compounds. Phytoch 26 (1987), 2197–2202.
17. [17] Simões, C.C., Araújo, D.B.D., Araújo, R.P.C.D., Estudo in vitro e ex vivo da ação de diferentes concetrações de extratos de própolis frente aos microrganismos presente na saliva de humanos. Rev. Bras. Farmacogn. 18 (2008), 84–89.
18. [18] CLSI-clinical and Laboratory Standards Institute Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A3, third ed., 2008, Clinical and Laboratory Standards Institute. NIH, Wayne - PA, USA.
19. [19] Santos, N.K.A., Coutinho, H.D.M., Viana, G.S.B., Rodrigues, F.F.G., Costa, J.G.M., Chemical characterization and synergistic antibiotic activity of volatile compounds from the essential oil of Vanillosmopsis arborea. Med. Chem. Res. 20 (2011), 637–641.
20. [20] Coutinho, H.D.M., Cordeiro, L.N., Bringel, K.P., Antibiotic resitance of pathogenic bacteriai solated from the population of Juazeiro do Norte-Ceara. Rev. Bras. Ciênc Saúde 9 (2005), 127–138.
21. [21] Coutinho, H.D.M., Costa, J.G.M., Siqueira-Júnior, J.P., Lima, E.O., In vitro anti-staphylococcal activity of Hyptis martiusii Benth against methicillin resistant Staphylococcus aureus-MRSA strains. Rev. Bras. Farmacogn. 18 (2008), 670–675.
22. [22] Prasad, N.R., Karthikeyan, A.S., Karthikeyan, B.V., Reddy, Inhibitory effect of caffeic acid on cancer cell proliferation by oxidative mechanism in human HT-1080 fibro sarcoma cell line. Mol. Cell Biochem. 349 (2011), 11–19.
23. [23] Fonseca, A.M., Constituents and antioxidant activity of two varieties of coconut water(Cocos nuciferaL.). Rev. Bras. Farmacogn. 19 (2009), 193–198.
24. [24] Fu, J., Cheng, K., Zhang, Z., Fang, R., Zhu, H., Synthesis, structure and structure–activity relationship analysis of caffeic acid amides as potential antimicrobials. Eur. J. Med. Chem. 45 (2010), 2638–2643.
25. [25] Aljadi, A.M., Yusoff, K.M., Isolation and identification of phenolic acids in Malaysian honey with antibacterial properties. Turk J. Med. Sci. 33 (2003), 229–236.
26. [26] Chun, S.S., Vattem, D.A., Lin, Y.T., Shetty, K., Phenolic antioxidants from clonal oregano (Origanum vulgare) with antimicrobial activity against Helicobacter pylori. Process Biochem. 40 (2005), 809–816.
27. [27] Takaisi, N.B., Scjoncjer, H., Electron microscopy and micro calorimetric investigations of the possible mechanism of the antibacterial action of a defined propole provenance. Planta Med. 60 (1994), 222–227.
28. [28] Alves, C.Q., Flavonóides antioxidantes e derivados de ácido gálico isolados de Cenostigma gardnerianum Tul. (Leguminosae). 2007, UFBA, Salvador – BA.
29. [29] Al-Zahrani, S.H.M., Antibacterial activities of gallic acid and gallic acid methylesteron methicillin-resistant Staphylococcus aureus. J. Am. Sci., 2012 87–12.
30. [30] Arbos, K.A., Stevani, P.C., Castanha, R.F., Atividade antimicrobiana, antioxidante e teor de compostos fenólicos em casca e amêndoa de frutos de manga. Rev. Ceres 60 (2013), 161–165.
31. [31] Kocaçalışkan, I., Talan, I., Terzi, I., Antimicrobial activity of catechol and pyrogallol as allelochemicals. Z Naturforsch 61 (2006), 639–642.
32. [32] Hirasawa, M., Takada, K., Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans. J. Antimicrob. Chemother. 53 (2004), 225–229.
33. [33] Leal, P.C., Síntese e avaliação da atividade antifúngica de compostos derivados do ácido gálico. MSc Thesis, 2004, UFSC, Florianópolis-SC, Brazil.
34. [34] Lattanzio, V., Lattanzio, V.M., Cardinali, A., Role of phenolics in the resistance mechanisms of plants against fungal pathogens and insects. Imperato, F., (eds.) Phytochemistry: Advances in Research, 2006, 23–67.
35. [35] Lima, C.P., Avaliação da atividade do ácido gálico sobre a formação de biofilme por Candida albicans. BSc thesis, 2014, UFG, Anápolis – GO, Brazil.
36. [36] Bufalo, M.C., Efeito da própolis e de compostos isolados sobre a expressão de receptores, produção de citocinas e atividade fungicida de monócitos humanos. PhD Thesis, 2013, UNESP, Botucatu-SP, Brazil.
37. [37] Hussin, N.M., Muse, R., Ahmad, S., Ramli, J., Mahmood, M., Sulaiman, M.R., Antifungal activity of extracts and phenolic compounds from Barringtonia racemosa L. (Lecythidaceae). Afr. J. Biotechnol. 8 (2009), 2835–2842.
38. [38] Singh, S., Srivastava, R., Choudhary, S., Antifungal and HPLC analysis of the crude extracts of Acoruscalamus, Tinospor acordifolia and Celestrus paniculatus. J. Agricul Technol. 61 (2010), 49–158.